Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis.
Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
Long-Term Data of Efficacy, Safety and Tolerability in a Real Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
Interplaying factors that effect multiple sclerosis causation and sustenance.
Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
Spatial modeling of multiple sclerosis for disease subtype prediction.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
Daclizumab for relapsing remitting multiple sclerosis.
Complications of Immunosuppressive/Immunomodulatory Therapy in Neurological Diseases.
Immunomodulatory therapies delay disease progression in multiple sclerosis.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.
Altered collagen expression in jugular veins in multiple sclerosis.
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities.
Treatment of primary progressive multiple sclerosis.
Immunological differences between classical phenothypes of multiple sclerosis.
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.
A phase-specific neuroimmune model of clinical depression.

Pages